866-997-4948(US-Canada Toll Free)

United States Melanoma Drugs Market Report 2017

Published By :

QYResearch

Published Date : Feb 2017

Category :

Pharmaceutical

No. of Pages : 123 Pages

Notes:
Sales, means the sales volume of Melanoma Drugs
Revenue, means the sales value of Melanoma Drugs

This report studies sales (consumption) of Melanoma Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Amgen
Bristol-Myers Squibb
Hoffmann-La Roche Ltd
Genentech Inc
Janssen Biotech
Novartis International AG
Pfizer, Sanofi
Takeda Pharmaceutical Company Limited
Teva Pharmaceuticals

Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Chemotherapy
Immunotherapy
Targeted Therapy
Split by applications, this report focuses on sales, market share and growth rate of Melanoma Drugs in each application, can be divided into
Hospital
Personal

Table of Contents

United States Melanoma Drugs Market Report 2017
1 Melanoma Drugs Overview
1.1 Product Overview and Scope of Melanoma Drugs
1.2 Classification of Melanoma Drugs
1.2.1 Chemotherapy
1.2.2 Immunotherapy
1.2.3 Targeted Therapy
1.3 Application of Melanoma Drugs
1.3.1 Hospital
1.3.2 Personal
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Melanoma Drugs (2012-2022)
1.4.1 United States Melanoma Drugs Sales and Growth Rate (2012-2022)
1.4.2 United States Melanoma Drugs Revenue and Growth Rate (2012-2022)

2 United States Melanoma Drugs Competition by Manufacturers
2.1 United States Melanoma Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Melanoma Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Melanoma Drugs Average Price by Manufactures (2015 and 2016)
2.4 Melanoma Drugs Market Competitive Situation and Trends
2.4.1 Melanoma Drugs Market Concentration Rate
2.4.2 Melanoma Drugs Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Melanoma Drugs Sales (Volume) and Revenue (Value) by States (2012-2017)
3.1 United States Melanoma Drugs Sales and Market Share by States (2012-2017)
3.2 United States Melanoma Drugs Revenue and Market Share by States (2012-2017)
3.3 United States Melanoma Drugs Price by States (2012-2017)

4 United States Melanoma Drugs Sales (Volume) and Revenue (Value) by Type (2012-2017)
4.1 United States Melanoma Drugs Sales and Market Share by Type (2012-2017)
4.2 United States Melanoma Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Melanoma Drugs Price by Type (2012-2017)
4.4 United States Melanoma Drugs Sales Growth Rate by Type (2012-2017)

5 United States Melanoma Drugs Sales (Volume) by Application (2012-2017)
5.1 United States Melanoma Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Melanoma Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Melanoma Drugs Manufacturers Profiles/Analysis
6.1 Amgen
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Melanoma Drugs Product Type, Application and Specification
6.1.2.1 Chemotherapy
6.1.2.2 Immunotherapy
6.1.3 Amgen Melanoma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Bristol-Myers Squibb
6.2.2 Melanoma Drugs Product Type, Application and Specification
6.2.2.1 Chemotherapy
6.2.2.2 Immunotherapy
6.2.3 Bristol-Myers Squibb Melanoma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Hoffmann-La Roche Ltd
6.3.2 Melanoma Drugs Product Type, Application and Specification
6.3.2.1 Chemotherapy
6.3.2.2 Immunotherapy
6.3.3 Hoffmann-La Roche Ltd Melanoma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Genentech Inc
6.4.2 Melanoma Drugs Product Type, Application and Specification
6.4.2.1 Chemotherapy
6.4.2.2 Immunotherapy
6.4.3 Genentech Inc Melanoma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Janssen Biotech
6.5.2 Melanoma Drugs Product Type, Application and Specification
6.5.2.1 Chemotherapy
6.5.2.2 Immunotherapy
6.5.3 Janssen Biotech Melanoma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Novartis International AG
6.6.2 Melanoma Drugs Product Type, Application and Specification
6.6.2.1 Chemotherapy
6.6.2.2 Immunotherapy
6.6.3 Novartis International AG Melanoma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Pfizer, Sanofi
6.7.2 Melanoma Drugs Product Type, Application and Specification
6.7.2.1 Chemotherapy
6.7.2.2 Immunotherapy
6.7.3 Pfizer, Sanofi Melanoma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Takeda Pharmaceutical Company Limited
6.8.2 Melanoma Drugs Product Type, Application and Specification
6.8.2.1 Chemotherapy
6.8.2.2 Immunotherapy
6.8.3 Takeda Pharmaceutical Company Limited Melanoma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Teva Pharmaceuticals
6.9.2 Melanoma Drugs Product Type, Application and Specification
6.9.2.1 Chemotherapy
6.9.2.2 Immunotherapy
6.9.3 Teva Pharmaceuticals Melanoma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview

7 Melanoma Drugs Manufacturing Cost Analysis
7.1 Melanoma Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Melanoma Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Melanoma Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Melanoma Drugs Major Manufacturers in 2015
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Melanoma Drugs Market Forecast (2017-2022)
11.1 United States Melanoma Drugs Sales, Revenue Forecast (2017-2022)
11.2 United States Melanoma Drugs Sales Forecast by Type (2017-2022)
11.3 United States Melanoma Drugs Sales Forecast by Application (2017-2022)
11.4 Melanoma Drugs Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix
Methodology
Analyst Introduction
Data Source

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *